PWM
AMRX icon

Parkworth Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Parkworth Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$24 Buy
+3
New +$23 ﹤0.01% 1333

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkworth Wealth Management's AMRX Position: Q2 2025 in Review

Parkworth Wealth Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2025: 3 shares worth $24. The stake represents ﹤0.01% of the portfolio and ranks #1333 among its holdings.

241 funds tracked by Wall St. Rank hold AMRX as of Q2 2025.

  • Parkworth Wealth Management held 3 shares of Amneal Pharmaceuticals worth $24 as of Q2 2025.
  • Amneal Pharmaceuticals was a new Parkworth Wealth Management position in Q2 2025.
  • Amneal Pharmaceuticals made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #1333 holding.
  • 241 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.